Oftac Eye Drops (0.05% Tacrolimus Ophthalmic Emulsion) for the Treatment of Active Non-infectious Anterior Uveitis
CompletedPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2024-03-07Est. Completion: 2025-03-25
Enrollment target: 18 participants
Locations
Department of Ophthalmology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beersheba, Israel
Department of Ophthalmology, Bnai Zion Medical Center, Haifa, Israel
Department of Ophthalmology, Carmel Medical Center, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
Department of Ophthalmology, Rambam Medical Center, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
Department of Ophthalmology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
Department of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel
Shamir Medical Center, Ẕerifin, Israel
Other microbiome trials you might be interested in